FLOSEAL HEMOSTATIC MATRIX ADS202105Recalls & reported problems
Baxter Healthcare Corporation · Floseal with Recothrom - 5mL · Class 3 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00085412827957), received between Jan 17, 2025 and Jan 17, 2025 — classified as 3 injuries.
3 other recalls cover devices cleared under the same FDA submission (P990009); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem3
Patient problems
- Fungal Infection3
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryJan 17, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE PATIENT UNDERWENT A LOWER SPINAL PROCEDURE WITH ¿HARDWARE IMPLANTED¿ (WITH ¿TRIPS BACK TO THE OPERATING ROOM FOR HARDWARE REPLACEMENT) WHEREIN FLOSEAL HEMOSTATIC MATRIX WAS APPLIED. THE PATIENT RECEIVED UNSPECIFIED PRE AND POST OPERATIVE ANTIBIOTICS. THE PATIENT WAS DISCHARGED FROM THE HOSPITAL WITHOUT ANY ISSUES WITH FOLLOW UP CARE WITH THE PHYSICIAN. APPROXIMATELY SIX TO EIGHT WEEKS POST OPERATIVELY, THE PATIENT VISITED THE PHYSICIAN, AND THE ¿SOURCE OF SURGERY¿ WAS NOTED TO BE INFECTED. BLOOD CULTURES WERE PERFORMED AND WERE POSITIVE FOR CANDIDA ALBICANS. IT WAS NOT REPORTED WHAT FROM OF MEDICAL INTERVENTION WAS PROVIDED. NO FURTHER INFORMATION WAS AVAILABLE AT THE TIME OF THIS REPORT.
Patient problems: Fungal Infection
MAUDE report 21185857 ↗InjuryJan 17, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE PATIENT UNDERWENT A LOWER SPINAL PROCEDURE WITH ¿HARDWARE IMPLANTED¿ (WITH ¿TRIPS BACK TO THE OPERATING ROOM FOR HARDWARE REPLACEMENT) WHEREIN FLOSEAL HEMOSTATIC MATRIX WAS APPLIED. THE PATIENT RECEIVED UNSPECIFIED PRE AND POST OPERATIVE ANTIBIOTICS. THE PATIENT WAS DISCHARGED FROM THE HOSPITAL WITHOUT ANY ISSUES WITH FOLLOW UP CARE WITH THE PHYSICIAN. APPROXIMATELY SIX TO EIGHT WEEKS POST OPERATIVELY, THE PATIENT VISITED THE PHYSICIAN, AND THE ¿SOURCE OF SURGERY¿ WAS NOTED TO BE INFECTED. BLOOD CULTURES WERE PERFORMED AND WERE POSITIVE FOR CANDIDA ALBICANS. IT WAS NOT REPORTED WHAT FROM OF MEDICAL INTERVENTION WAS PROVIDED. NO FURTHER INFORMATION WAS AVAILABLE AT THE TIME OF THIS REPORT.
Patient problems: Fungal Infection
MAUDE report 21185856 ↗InjuryJan 17, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE PATIENT UNDERWENT A LOWER SPINAL PROCEDURE WITH ¿HARDWARE IMPLANTED¿ (WITH ¿TRIPS BACK TO THE OPERATING ROOM FOR HARDWARE REPLACEMENT) WHEREIN FLOSEAL HEMOSTATIC MATRIX WAS APPLIED. THE PATIENT RECEIVED UNSPECIFIED PRE AND POST OPERATIVE ANTIBIOTICS. THE PATIENT WAS DISCHARGED FROM THE HOSPITAL WITHOUT ANY ISSUES WITH FOLLOW UP CARE WITH THE PHYSICIAN. APPROXIMATELY SIX TO EIGHT WEEKS POST OPERATIVELY, THE PATIENT VISITED THE PHYSICIAN, AND THE ¿SOURCE OF SURGERY¿ WAS NOTED TO BE INFECTED. BLOOD CULTURES WERE PERFORMED AND WERE POSITIVE FOR CANDIDA ALBICANS. IT WAS NOT REPORTED WHAT FROM OF MEDICAL INTERVENTION WAS PROVIDED. NO FURTHER INFORMATION WAS AVAILABLE AT THE TIME OF THIS REPORT.
Patient problems: Fungal Infection
MAUDE report 21185815 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P990009. One submission often covers many models, so check the product and lot details in each record.
- Z-0667-2024 · Dec 6, 2023 · Open, ClassifiedBaxter FloSeal Hemostatic Matrix NL, 5 mL, Product Codes: ADS201883
- Z-2957-2018 · May 30, 2018 · Open, ClassifiedFLOSEAL Special Applicator Tips in cartons labeled in part, "Floseal SPECIAL APPLICATOR TIPS***6 x Malleable Tip Trimmable Tip***Baxter***." The pouches inside the cartons are lab
- Z-2340-2008 · Jul 31, 2008 · TerminatedFloSeal Endoscopic Applicator , Product Code 1500181. The product is indicated in surgical procedures (other than in neurosurgical, opthalmic, and urological) as an adjunct to hem
Other Absorbable collagen hemostatic agent with thrombin devices
- HEMOBLAST Bellows BQF02Dilon Technologies France · Absorbable Collagen Hemostatic Agent With Thrombin3 reports
- FLOSEAL HEMOSTATIC MATRIX ADS201845Baxter Healthcare Corporation · Absorbable collagen hemostatic agent with thrombin2 reports
- Floseal 1505291Baxter Healthcare Corporation · Absorbable collagen hemostatic agent with thrombin1 report
- FLOSEAL HEMOSTATIC MATRIX ADS201844Baxter Healthcare Corporation · Absorbable collagen hemostatic agent with thrombin1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page